“A public company must have at least 3 directors (not counting...

First 5 Last

Share
Profile

Follow
friendlydwarves

3,521 Posts.

495

01/12/23

21:06

Post #: 71228337
Share

Originally posted by Retired123: ↑

10% reduction in directors' fees. Nero fiddles..... Should have been 50% and director numbers cut from 4 to 2 rather than 4 to 3. Nothing is happening at board level and at business level not much else. Shuffling the deckchairs. Chairman's comment about "dismal" performance says it all. No investment winners in years and they think they are experts. Get a life and wind the company up and put SHs out of their misery.

Apart from tightening their belts the address said nothing about what's happening at business level. Probably because nothing is happening apart from directors taking their fees for doing nothing that adds value to the company. Probably the worst company I have ever invested in in 30 years. So glad I bailed out at a small loss years ago.

Hubris reigns supreme. Good luck to all suffering SHs. It has been a slow grind down which will probably continue until cash balances run out. That's when hopefully directors will shut up shop but that's years away. Still $5m in the bank that will last another 6 years of pain. See historic performance below. Note these are annual returns so they have lost 19% every year since 2015. And they call themselves investment experts. What a joke.

Expand

“A public company must have at least 3 directors (not counting alternate directors). At least 2 directors must ordinarily reside in Australia.” - Corporations Act s201A(2)

HGV Price at posting: 5.2¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

MXR

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

PCK

PainChek close to finding out if FDA approves its flagship app for use in dementia care

There are more pages in this discussion • 6 more messages in this thread...

First 5 Last

Add HGV (ASX) to my watchlist

(20min delay)
Last 5.4¢		Change 0.000(0.00%)		Mkt cap ! $11.35M

Open	High	Low	Value	Volume
5.4¢	5.4¢	5.4¢	$540	10K

Buyers (Bids)

No.	Vol.	Price($)
1	65026	5.0¢

Sellers (Offers)

Price($)	Vol.	No.
5.2¢	35278	1

View Market Depth

No.	Vol.	Price($)
1	65026	0.050
1	36712	0.046
3	327412	0.045
1	150000	0.044
1	119000	0.042

Price($)	Vol.	No.
0.052	35278	1
0.053	26668	1
0.054	9999	1
0.055	129870	1
0.057	16111	1

Last trade - 10.04am 02/10/2024 (20 minute delay)

HGV (ASX) Chart

“A public company must have at least 3 directors (not counting...

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

PainChek close to finding out if FDA approves its flagship app for use in dementia care

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

“A public company must have at least 3 directors (not counting...

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t

PainChek close to finding out if FDA approves its flagship app for use in dementia care

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News